FUNDAMENTAL OF HIV TESTING AND PREVENTION
Date: Feb 25, 2020 09:30 AM - Feb 26, 2020 02:40 PM
Fee
$0.00
CE Hours
3.00
CE Units
0.300
Registration closes on Apr 25, 2020 11:30 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacist
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Tue, Feb 25, 2020
Registration closes on Apr 25, 2020
at 11:30 PM
Tue, Feb 25, 2020
Registration closes on Apr 25, 2020
at 11:30 PM
PRE-EXPOSURE PROPHYLAXIS FOR HIV: PROVIDER EDUCATION
Registration Closed
PRE-EXPOSURE PROPHYLAXIS FOR HIV: PROVIDER EDUCATION
Registration Closed
Objectives
- Describe PrEP, including the goal(s) of therapy.
- Identify risk factors for PrEP eligibility.
- Explain the requirements for PrEP initiation.
- List the monitoring parameters for patients on PrEP
- Describe the role of community pharmacists in the management of PrEP
Speaker(s)/Author(s)
|
OLUFUNMI ARIYO, PHARM.D, AAHIVP |
Activity Number
0010-9999-20-005-L02-P
Date:
02/25/20
Time:
12:30 PM - 01:30 PM
CE Hours
1.00
Registration Closed
PATIENT CENTERED HIV CARE
Registration Closed
PATIENT CENTERED HIV CARE
Registration Closed
Objectives
- Describe the evolving DHHS treatment guidelines for when to start patients on ARV therapy
- Explain the HIV life cycle and treatment targets
- Describe adherence strategies to optimize HIV viral suppression
- Identify lifestyle and behaviors that can impact adherence
Speaker(s)/Author(s)
|
CHRISTOPHER ROBERSON, MS, ACRN, AAHIVS |
Activity Number
0010-9999-20-006-L02-P
Date:
02/25/20
Time:
01:30 PM - 02:00 PM
CE Hours
0.50
Registration Closed
Wed, Feb 26, 2020
Registration closes on Apr 25, 2020
at 11:30 PM
Wed, Feb 26, 2020
Registration closes on Apr 25, 2020
at 11:30 PM
ENCORE_FEBRUARY 26TH_PRE-EXPOSURE PROPHYLAXIS FOR HIV: PROVIDER EDUCATION
Registration Closed
ENCORE_FEBRUARY 26TH_PRE-EXPOSURE PROPHYLAXIS FOR HIV: PROVIDER EDUCATION
Registration Closed
Objectives
- Describe PrEP, including the goal(s) of therapy
- Identify risk factors for PrEP eligibility
- Explain the requirements for PrEP initiation
- List the monitoring parameters for patients on PrEP
- Describe the role of community pharmacists in the management of PrEP
Speaker(s)/Author(s)
|
OLUFUNMI ARIYO, PHARM.D, AAHIVP |
Activity Number
0010-9999-20-005-L02-P
Date:
02/26/20
Time:
12:30 PM - 01:30 PM
CE Hours
1.00
Registration Closed
ENCORE_FEBRUARY 26TH_PATIENT CENTERED HIV CARE
Registration Closed
ENCORE_FEBRUARY 26TH_PATIENT CENTERED HIV CARE
Registration Closed
Objectives
- Describe the evolving DHHS treatment guidelines for when to start patients on ARV therapy
- Explain the HIV life cycle and treatment targets
- Describe adherence strategies to optimize HIV viral suppression
- Identify lifestyle and behaviors that can impact adherence
Speaker(s)/Author(s)
|
CHRISTOPHER ROBERSON, MS, ACRN, AAHIVS |
Activity Number
0010-9999-20-006-L02-P
Date:
02/26/20
Time:
01:30 PM - 02:00 PM
CE Hours
0.50
Registration Closed